Gastroenterology:乳糜泻患者可以食用燕麦

2017-04-20 zhangfan MedSci原创

通过对一系列临床研究的汇总荟萃分析,没有发现任何,组织学,免疫,或腹腔疾病患者的血清学特征证据表明燕麦对无麸质饮食患者症状的影响

乳糜泻患者应保持除小麦,黑麦和大麦外的无麸质饮食(GFD)。燕麦可以增加无麸质饮食的营养成分但是对于燕麦的添加还存在争议。研究人员近日对乳糜泻患者GFD添加燕麦进行了系统回顾与荟萃分析。

研究对几年来腹腔疾病的患者GFD添加燕麦的临床试验进行汇总,这些研究报告了患者的症状、血清学检查结果和组织学分析结果。我们使用等级的方法(GRADE)来评估有关的证据。

近年来共有433项相关临床试验,其中28起满足本研究课题纳入本数据分析中,其中有6项为随机对照试验、2项为非随机对照试验其余为观察研究,共包含661名患者。所有的随机对照试验均使用纯/无公害燕麦。研究发现,食用燕麦12个月对患者病情(标准平均差异:患者服用燕麦以否对症状减缓得分为-0.22;95% CI -0.56至0.13;p=0.22),组织学评分(服用燕麦患者组织学检查的相对风险为0.24;95% CI 0.01-4.8 P=0.35),上皮内淋巴细胞计数和血清学试验结果(标准平均差为0.21)未产生影响。成人或儿童亚组显示无差异。燕麦会加重乳糜泻患者病情的证据可信度较低。

研究认为,通过对一系列临床研究的汇总荟萃分析,没有发现任何,组织学,免疫,或腹腔疾病患者的血清学特征证据表明燕麦对无麸质饮食患者症状的影响,然而目前对于该研究的临床试验涉及较少,需要大规模的临床对照试验研究燕麦对于无麸质饮食患者症状的影响。

原文出处:

María Inés et al. Safety of Adding Oats to a Gluten-free Diet for Patients with Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology April 18, 2017

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2064072, encodeId=687720640e27c, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Mon Jun 26 05:25:00 CST 2017, time=2017-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1711011, encodeId=31ea1e110114c, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Mon Oct 16 17:25:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071742, encodeId=2f2e20e1742d8, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Mon Aug 28 22:25:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504272, encodeId=9a2a15042e201, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Sat Apr 22 02:25:00 CST 2017, time=2017-04-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2064072, encodeId=687720640e27c, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Mon Jun 26 05:25:00 CST 2017, time=2017-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1711011, encodeId=31ea1e110114c, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Mon Oct 16 17:25:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071742, encodeId=2f2e20e1742d8, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Mon Aug 28 22:25:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504272, encodeId=9a2a15042e201, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Sat Apr 22 02:25:00 CST 2017, time=2017-04-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2064072, encodeId=687720640e27c, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Mon Jun 26 05:25:00 CST 2017, time=2017-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1711011, encodeId=31ea1e110114c, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Mon Oct 16 17:25:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071742, encodeId=2f2e20e1742d8, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Mon Aug 28 22:25:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504272, encodeId=9a2a15042e201, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Sat Apr 22 02:25:00 CST 2017, time=2017-04-22, status=1, ipAttribution=)]
    2017-08-28 许安
  4. [GetPortalCommentsPageByObjectIdResponse(id=2064072, encodeId=687720640e27c, content=<a href='/topic/show?id=94ffe853a7' target=_blank style='color:#2F92EE;'>#Gastroenterol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7853, encryptionId=94ffe853a7, topicName=Gastroenterol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bed488, createdName=jktdtl, createdTime=Mon Jun 26 05:25:00 CST 2017, time=2017-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1711011, encodeId=31ea1e110114c, content=<a href='/topic/show?id=9a1c289680' target=_blank style='color:#2F92EE;'>#AST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2896, encryptionId=9a1c289680, topicName=AST)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b9831894722, createdName=ms24272190615788285182, createdTime=Mon Oct 16 17:25:00 CST 2017, time=2017-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071742, encodeId=2f2e20e1742d8, content=<a href='/topic/show?id=9d4ee84647' target=_blank style='color:#2F92EE;'>#GAS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7846, encryptionId=9d4ee84647, topicName=GAS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2dd327, createdName=许安, createdTime=Mon Aug 28 22:25:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1504272, encodeId=9a2a15042e201, content=<a href='/topic/show?id=7730e85412' target=_blank style='color:#2F92EE;'>#Gastroenterology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7854, encryptionId=7730e85412, topicName=Gastroenterology)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5fc29706655, createdName=chaojitidian, createdTime=Sat Apr 22 02:25:00 CST 2017, time=2017-04-22, status=1, ipAttribution=)]

相关资讯

武田携手PvP开发乳糜泻治疗药物KumaMax,在胃中降解谷蛋白

日本制药巨头武田(Takeda)近日宣布与美国生物技术公司PvP Biologics达成一项全球协议,合作开发一种乳糜泻治疗药物KumaMax,这是一种独特设计的重组酶,在人体胃内的酸性条件下具有活性,针对谷蛋白(gluten)中可引起乳糜泻相关自身免疫反应的部分具有非常高的特异性,可在胃中降解谷蛋白中的免疫反应性部分,从而避免乳糜泻患者因意外摄入谷蛋白所导致的痛苦症状和肠道损害。根据协议条款,

盘点:近期乳糜泻研究进展一览

乳糜泻是一种自身免疫性消化功能紊乱,有遗传倾向的个体会对存在于谷物、小麦、黑麦和大麦中的谷蛋白产生一种免疫反应。大约有40%人群具有与乳糜泻相关的主要基因变异,但只有1%携带这些基因的人会在摄取谷蛋白后进一步发展为肠炎和肠损伤——这一疾病的标志。【1】乳糜泻患者对Nexvax2疫苗耐受良好根据2016消化疾病周给出的数据,Nexvax2,一种可以防止特定乳糜泻患者谷蛋白暴露的治疗性疫苗,在对疫

谷蛋白在一些乳糜泻患者中引发淋巴瘤

乳糜泻是由消耗麸质引发的自身免疫性疾病。该疾病影响了美国的几百万人,新的研究表明,这些人中的一些甚至可能在消耗麸质时发展为罕见癌症。乳糜泻影响约 300 万美国成年人,约占该国健康成年人口的 1%。该疾病是遗传性自身免疫病症。对于患有乳糜泻的人来说,消耗谷蛋白 - 在谷物如小麦,黑麦和大麦中发现的蛋白质 - 导致其免疫系统攻击小肠。如果不治疗,乳糜泻可能导致并发症,例如骨质疏松症,不育症,一些脑病

2017年4月7日Science期刊精华

图片来自Science期刊。 2017年4月9日/生物谷BIOON/---本周又有一期新的Science期刊(2017年4月7日)发布,它有哪些精彩研究呢?让小编一一道来。 1.Science:发现一类新的巨病毒携带着有史以来最多的蛋白翻译相关基因 doi:10.1126/science.aal4657; doi:10.1126/science.356.6333.15 病毒在地球

2015NICE指南——乳糜泻的识别,评估和管理(NG.20)发布

2015年9月,英国国家卫生与临床优化研究所 (NICE)发布了乳糜泻的识别,评估和管理指南。全文获取:下载地址:指南下载(需要扣积分2分, 梅斯医学APP免积分下载) 

摄入谷蛋白真的能帮助预防2型糖尿病?

2017年3月24日 讯 /生物谷BIOON/ --近日研究人员进行的一项大规模研究观察了食物对将近20万名美国健康专业人士健康的影响和效应,结果表明,摄入高水平的谷蛋白或许和个体2型糖尿病风险降低直接相关?那么事实真的这么简单吗? 谷蛋白和糖尿病发病相关? 近年来研究人员进行了大量研究来阐明乳糜泻和1型糖尿病之间的潜在关联,研究者发现,这些疾病之间或许拥有着和机体免疫系统相关的类似的